Sign Up
bf/NASDAQ:CGEM_icon.png

COM:CULLINANONCOLOGY

Cullinan Oncology

  • Stock

Last Close

12.22

22/11 21:00

Market Cap

923.88M

Beta: -

Volume Today

464.95K

Avg: -

OverviewAnalysisMetricsFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
615K
-
5.31M
762.85%
6.42M
21.06%
2.91M
54.63%
2.58M
11.60%
average receivables
book value per share
-1.80
-
-2.11
16.76%
-1.88
10.94%
9.81
623.05%
11.85
20.76%
10.92
7.82%
capex per share
-0.02
-
-0.00
95.47%
-0.00
76.62%
-0.03
-
-0.01
80.04%
capex to depreciation
-6.07
-
-0.29
95.29%
-0.16
43.55%
-12.18
-
-0.67
94.49%
capex to operating cash flow
0.02
-
0.00
95.03%
0.00
64.90%
0.01
-
0.00
82.68%
capex to revenue
cash per share
2.95
-
5.09
72.40%
5.08
0.32%
15.36
202.45%
19.07
24.17%
11.24
41.05%
days of inventory on hand
days payables outstanding
2.94K
-
days sales outstanding
debt to assets
0.01
-
0.01
19.97%
debt to equity
0.01
-
0.01
18.41%
dividend yield
earnings yield
-0.04
-
-0.03
16.49%
-0.04
18.69%
-0.10
138.28%
0.23
338.53%
-0.36
254.99%
enterprise value
308.63M
-
515.85M
67.14%
1.07B
107.43%
233.82M
78.15%
-68.45M
129.27%
328.55M
579.99%
enterprise value over ebitda
-21.22
-
-23.24
9.49%
-17.73
23.68%
-3.44
80.60%
0.17
104.86%
-1.73
1,131.21%
ev to operating cash flow
-22.78
-
-24.69
8.37%
-35.94
45.59%
-5.38
85.02%
0.54
110.04%
-2.45
552.79%
ev to sales
12.34
-
free cash flow per share
-1.21
-
-1.08
10.43%
-0.72
33.41%
-1.01
40.15%
-2.83
180.64%
-3.24
14.38%
free cash flow yield
-0.04
-
-0.04
10.43%
-0.02
33.41%
-0.07
171.67%
-0.27
310.46%
-0.32
18.43%
graham net net
-1.87
-
-2.16
15.03%
-1.95
9.42%
15.08
872.41%
18.49
22.60%
10.49
43.27%
graham number
7.09
-
7.00
1.26%
7.20
2.81%
18.26
153.56%
25.62
40.34%
30.09
17.47%
income quality
0.95
-
0.97
1.06%
0.50
48.11%
0.64
28.53%
-1.16
280.23%
0.88
175.58%
intangibles to total assets
0
-
0
0
0
0
0
interest coverage
-0.26
-
interest debt per share
-12.34
-
0.09
100.70%
inventory turnover
invested capital
0.01
-
0.01
18.41%
market cap
342.46M
-
579.10M
69.10%
1.24B
113.82%
664.68M
46.32%
476.48M
28.31%
423.39M
11.14%
net current asset value
-21.07M
-
-40.28M
91.16%
-78.77M
95.56%
284.75M
461.51%
448.38M
57.46%
448.99M
0.14%
net debt to ebitda
2.33
-
2.85
22.47%
2.79
2.15%
6.34
127.44%
1.33
78.98%
0.50
62.61%
net income per share
-1.24
-
-1.03
16.49%
-1.23
18.69%
-1.51
22.92%
2.46
263.09%
-3.69
249.70%
operating cash flow per share
-1.18
-
-1.08
8.79%
-0.72
33.37%
-1.01
40.20%
-2.80
178.15%
-3.23
15.23%
payables turnover
0.12
-
receivables turnover
research and ddevelopement to revenue
3.05
-
return on tangible assets
-0.41
-
-0.20
51.31%
-0.24
18.74%
-0.15
37.18%
0.20
233.23%
-0.32
259.30%
revenue per share
0.44
-
roe
0.69
-
0.49
28.48%
0.65
33.27%
-0.15
123.50%
0.21
235.05%
-0.34
262.40%
roic
0.73
-
0.51
30.39%
0.66
31.49%
-0.15
123.32%
0.19
223.53%
-0.38
298.66%
sales general and administrative to revenue
1.54
-
shareholders equity per share
-1.80
-
-2.11
16.76%
-1.88
10.94%
9.81
623.05%
11.85
20.76%
10.92
7.82%
stock based compensation to revenue
1.29
-
tangible asset value
-20.65M
-
-39.91M
93.26%
-76.34M
91.28%
425.37M
657.22%
535.03M
25.78%
453.89M
15.16%
tangible book value per share
-1.80
-
-2.06
14.29%
-1.84
10.54%
9.87
635.50%
11.85
19.97%
10.92
7.79%
working capital
32.90M
-
97.57M
196.60%
197.96M
102.89%
284.82M
43.88%
451.97M
58.69%
452.05M
0.02%

All numbers in (except ratios and percentages)